transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65

used in the operation of the business, (3) to assess the adequacy and appropriateness of the allowance for inventory, and (4) to review and adjust the data used to measure the fair value of biological

initiatives such as poverty mitigation, sustainable tourism, preservation of biological diversity, promotion of transparency of government procurement, and promotion of public service innovations. UNDP Thailand

provisions for litigation in the amount of 12 million baht and 2 subsidiaries have a provision for the litigation of 1.13 million baht. 4. Loss arising from change in fair value of biological assets increase

period (as of June 30, 2020 and 2019, respectively). 6. Loss arising from changes in fair value of biological assets increased by Baht 4.73 million compared with the same period of the previous year

by the end of accounting period (as of December 31, 2018 and 2017). - Other income from gain arising from change in fair value of biological assets which increased by amount of Baht 12 million

% Investment in associated company 483.96 36% 474.65 7% Property, plant and equipment 558.59 42% 557.68 5% Biological assets – dairy cow 44.28 3% 38.56 3% Others 61.09 4% 52.82 4% Total assets 1,345.45 100

8.34 million, or 26.62%, in the year 2021 cause was more commission income in of 2021, which decreased by Baht 12.76 million and gain from changes in fair value of biological assets - dairy cow to Baht

, compared to the same period of the previous year had amount of Baht 7 million, increased by amount of Baht 14 million. 3. Other incomes from gain arising from change in fair value of biological assets which

of biological assets to ensure its appropriateness. EE is also required to rectify the financial statements for the year 2023 and the third quarter of 2024 and then submit the rectified financial